Ovarian cancer

Exam relevance: in 51 of more than 150 board exam reports · rank 6

Specialty
Gynaecology · Ovary & adnexa
Images
Histology & cytology 1 · Ultrasound 1 · Endoscopy & gross 1
Exam relevance
51 of more than 150 reports · rank 6
In the app
4 flashcards · GynFuchs
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (3)
  2. Classification
  3. Aetiopathogenesis
  4. Clinical features
  5. Histology
  6. Diagnosis
  7. Treatment principles
  8. Keep learning in the app
  9. Further reading (selection)
  10. Cross-references

Images (3)

Ovarian cancer – Laparoscopy: bilateral ovarian tumours with tumour seeding in the lesser pelvis (histologically this case was a lymphoma, macroscopically the picture of an ovarian carcinoma)Histology & cytology
Laparoscopy: bilateral ovarian tumours with tumour seeding in the lesser pelvis (histologically this case was a lymphoma, macroscopically the picture of an ovarian carcinoma)Image: Cheng IN, Chang C, Tsai HM, Hsu YT, Huang YF. (Discover oncology 2025) · CC BY 4.0 · Source · cropped
Ovarian cancer – ultrasound image: Free fluid in the pouch of Douglas next to the uterus and ovaryUltrasound
Free fluid in the pouch of Douglas next to the uterus and ovaryImage: Mikael Häggström (Wikimedia Commons) · CC0 · Source · cropped
Ovarian cancer – endoscopyEndoscopy & gross
Ovarian cancer – endoscopyImage: Cheng IN, Chang C, Tsai HM, Hsu YT, Huang YF. (Discover oncology 2025) · CC BY 4.0 · Source · cropped
1 / 3

Classification

Stages

  • FIGO I: FIGO stage I describes a tumour limited to the ovaries or fallopian tubes.
  • FIGO IC: A stage FIGO IC is present with capsule rupture, tumour on the surface, or positive washings or ascites cytology.
  • FIGO II: FIGO stage II means spread within the lesser pelvis.
  • FIGO III: FIGO stage III describes peritoneal metastases outside the lesser pelvis or retroperitoneal lymph node metastases.
  • FIGO IV: FIGO stage IV includes distant metastases, with malignant pleural effusion considered IVA.

Three groups

  • Tissue of origin: Based on their tissue of origin, they are classified into epithelial tumours, germ cell tumours, and sex cord-stromal tumours.
  • Frequency: The majority of all ovarian carcinomas are epithelial tumours.
  • Fourth group: A fourth, non-primary group consists of metastases from other organs to the ovary.

Aetiopathogenesis

Who is tested

  • Test material: Testing is performed on the germline from blood and additionally the tumour for somatic mutations and homologous recombination deficiency.
  • Prevalence: About one in five ovarian cancers carries a germline mutation in BRCA1 or BRCA2.

Clinical features

Why it is detected late

  • Early symptoms: The early symptoms of ovarian cancer are non-specific — increased abdominal girth, a feeling of fullness, loss of appetite, digestive and urinary problems.
  • Spread: The spread is predominantly intraperitoneal through the shedding of tumour cells along the peritoneal surfaces.
  • Frequent co-involvement: Due to the route of spread, ovarian cancer frequently involves the bowel with its serosal lining.

More facts from the study questions

  • FIGO stage I describes a tumour confined to the ovaries or fallopian tubes.
  • This represents the earliest stage of the disease.
  • FIGO stage IC applies to a tumour confined to the ovaries if additional criteria are met.
  • These include capsule rupture, tumour growth on the ovarian surface, or positive ascites/peritoneal washings.
  • FIGO stage IV comprises distant metastases.
  • A malignant pleural effusion is specifically classified as stage IVA.
  • FIGO stage II is defined as tumour spread within the pelvis.
  • This can include involvement of the uterus, bladder, or rectum, for example.
  • Peritoneal metastases outside the pelvis correspond to FIGO stage III.
  • FIGO stage II describes spread that is confined to the pelvis.

Histology

Epithelial tumours

  • Most common type: The most common type of ovarian carcinoma is high-grade serous carcinoma.
  • Origin of HGSC: According to current understanding, its origin is often in the fimbrial end of the fallopian tube, arising from a serous tubal intraepithelial carcinoma.
  • Association: Clear cell and endometrioid carcinomas are associated with endometriosis.

Diagnosis

Clinical work-up

  • Clinical examination: Additionally, a clinical examination is performed rectovaginally, of the inguinal lymph nodes and the supraclavicular region.

CA 125

  • Definition: CA 125 is a glycoprotein of the coelomic epithelium that is elevated in about 80 percent of serous ovarian carcinomas.
  • False-positive elevation: CA 125 is falsely elevated in endometriosis, fibroids, adnexitis, pregnancy, liver cirrhosis, ascites, and any peritoneal irritation.

HE4 and ROMA

  • Advantage of HE4: The advantage of human epididymis protein 4 (HE4) over CA 125 is that it does not rise in endometriosis and is therefore more specific.
  • ROMA index: The ROMA index calculates CA 125 and HE4 with the menopausal status to determine a risk probability.
  • Utility: The utility of the ROMA index lies in the triage of unclear adnexal masses, supplementary to ultrasound — not as a replacement for it.

Treatment principles

  • The cornerstone is surgery in an experienced centre with complete staging, aiming for no macroscopic residual disease; apart from very early, well-differentiated stages, this is followed by platinum-based combination chemotherapy.
  • In advanced disease, maintenance therapy with angiogenesis inhibitors or PARP inhibitors is added depending on BRCA and homologous recombination status; germline testing is offered to all patients.
  • At recurrence, treatment depends on whether the tumour is platinum-sensitive; repeat surgery may be considered in selected patients.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Ovarian cancer with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

In the app: 4 flashcards on this topic

Open in browser  About GynFuchs →

Further reading (selection)

  1. StatPearls: Epithelial Ovarian Cancer (NCBI Bookshelf)
  2. DocCheck Flexikon, Ovarialkarzinom
  3. DocCheck Flexikon, Ovarialtumor
  4. DocCheck Flexikon, CA 125
  5. DocCheck Flexikon, BRCA1

Cross-references

Keep learning: test yourself

One question from the GynFuchs app on Ovarian cancer – tap an answer.

Question 1 of 1

Why it is detected late: Early symptoms: The early symptoms of ovarian cancer are _____.

Answer

Correct: non-specific — increased abdominal girth, a feeling of fullness, loss of appetite, digestive and urinary problems. Early symptoms: The early symptoms of ovarian cancer are non-specific — increased abdominal girth, a feeling of fullness, loss of appetite, digestive and urinary problems.

More questions like these – with explanations and spaced repetition – in the app.

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.